IPV Vaccines Market Size is Valued at USD 183.96 Million in 2023 and is Projected to Reach USD 383.35 Million by 2032, Growing at a CAGR of 8.50% From 2024-2032. Market Overview The global production, distribution, and supply of vaccines made from a weakened inactivated poliovirus and used to immunize against poliomyelitis are all included in the IPV (Inactivated Poliovirus) Vaccines...